Current Prices from Chromocell Therapeutics Corporation Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NYSE	CHRO	USD	13.06.2025 21:24	1,28 USD	1,34 USD -4,48 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-4,48 %	12,31 %	19,63 %	-22,89 %	85,78 %	-0,78 %	-73,33 %

Company Profile for Chromocell Therapeutics Corporation Common Stock Share

Channel Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Company Data

Name Chromocell Therapeutics Corporation Common Stock

Company Channel Therapeutics Corporation

Symbol CHRO

Website https://chromocell.com

Primary Exchange

NYSE

ISIN US1711261057

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Francis Knuettel II, M.B.A.

Market Capitalization 11 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 4400 Route 9 South, 07728 Freehold

IPO Date 2024-02-16

Ticker Symbols

Name	Symbol
NYSE	CHRO

More Shares

Investors who Chromocell Therapeutics Corporation Common Stock hold also have the following shares in their portfolio:

SG ISSUER NTS 22/01/31 Bond

TUATARA CAPITAL ACQUISITIONCORP - CLASS A Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog